Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: A controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam

Alcohol and Alcoholism

Volumn 38, Issue 2, 2003, Pages 168-175

  Lucht, M ^a   Kuehn, K U ^a   Armbruster, J ^a   Abraham, G ^a   Gaensicke, M ^a   Barnow, S ^a   Tretzel, H ^a   Freyberger, H J ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE; CARBAMAZEPINE; CLOMETHIAZOLE; DIAZEPAM; TIAPRIDE;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANGER; ANXIETY NEUROSIS; ARTICLE; ATAXIA; BREATH ANALYSIS; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM TREMENS; DEPRESSION; DIPLOPIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HOSTILITY; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PHOBIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SOMATIZATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOL WITHDRAWAL SEIZURES; ALCOHOLIC INTOXICATION; ALCOHOLISM; ANALYSIS OF VARIANCE; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; CHI-SQUARE DISTRIBUTION; CHLORMETHIAZOLE; DIAZEPAM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; TIAPRIDE; TREATMENT OUTCOME;

ATAXIA;

EID: 0037346416     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agg050     Document Type: Article

References (44)

1. Addolorato, G., Castelli, E., Stefanini, G. F., Casella, G., Caputo, F., Marsigli, L., Bernardi, M. and Gasbarrini, G. (1996) An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol and Alcoholism 31, 341-345.
2. Addolorato, G., Balducci, G., Capristo, E., Attilia, M. L., Taggi, F., Gasbarrini, G. and Ceccanti, M. (1999) Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcoholism: Clinical and Experimental Research 23, 1596-1604.
3. Agricola, R., Mazzarino, M., Urani, R., Gallo, V. and Grossi, E. (1982) Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with tiapride. Journal of International Medical Research 10, 160-165.
4. Ballenger, J. C. and Post, R. M. (1978) Kindling as a model for alcohol withdrawal syndromes. British Journal of Psychiatry 133, 1-14.
5. Beghe, F. and Carpanini, M. T. (2000) Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients. Alcohol 20, 223-225.
6. Benkert, O. and Hippius, H. (1998) Kompendium der psychiatrischen Pharmakotherapie. Springer, Berlin.
7. Boyce, S. H., Padgham, K., Miller, L. D. and Stevenson, J. (2000) Gamma hydroxybutyric acid (GHB): an increasing trend in drug abuse. European Journal of Emergency Medicine 7, 177-181.
8. Derogatis, L. R. (1983) Symptom Checklist 90-R: Administration, Scoring and Procedures Manual. Clinical Psychometric Research, Baltimore.
9. DiBello, M. G., Gambassi, F., Mugnai, L., Masini, E. and Mannaioni, P. F. (1995) Gamma-hydroxybutyric acid induced suppression and prevention of alcohol withdrawal syndrome and relief of craving in alcohol dependent patients. Alcologia 7, 9-16.
10. Franz, M., Dlabal, H., Kunz, S., Ulferts, J., Gruppe, H. and Gallhofer, B. (2001) Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. European Archives of Psychiatry and Clinical Neuroscience 251, 185-192.
11. Gallimberti, L., Canton, G., Gentile, N., Ferri, M., Cibin, M., Ferrara, S. D., Fadda, F. and Gessa, G. L. (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet ii, 787-789.
12. Gallimberti, L., Ferri, M., Ferrara, S. D., Fadda, F. and Gessa, G. L. (1992) gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcoholism: Clinical and Experimental Research 16, 673-676.
13. Glue, P. and Nutt, D. (1990) Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. British Journal of Psychiatry 157, 491-499.
14. Guardia, J., Catafau, A. M., Batlle, F., Martin, J. C., Segura, L., Gonzalvo, B., Prat, G., Carrio, I. and Casas, M. (2000) Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. American Journal of Psychiatry 157, 127-129.
15. Heinz, A., Schmidt, K., Baum, S. S., Kuhn, S., Dufeu, P., Schmidt, L. G. and Rommelspacher, H. (1996) Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. Journal of Studies on Alcohol 57, 471-474.
16. Hertling, I., Ramskogler, K., Riegler, A., Zoghlami, A., Walter, H. and Lesch, O. M. (2001) Entzugsbehandlung von alkoholabhängigen Patienten. Wiener Zeitschrift für Suchtforschung 24, 41-46.
17. Lepola, U., Kokko, S., Nuutila, J. and Gordin, A. (1984) Tiapride and chlordiazepoxide in acute alcohol withdrawal. A controlled clinical trial. International Journal of Clinical Pharmacological Research 4, 321-326.
18. Li, J., Stokes, S. A. and Woeckener, A. (1998) A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Annals of Emergency Medical 31, 729-736.
19. Lucht, M. J., Kuehn, K. U., Schroeder, W., Armbruster, J., Abraham, G., Schattenberg, A., Gaensicke, M., Barnow, S., Tretzel, H., Herrmann, F. H. and Freyberger, H. J. (2001) Influence of the dopamine D2 receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawal. Pharmacogenetics 11, 647-653.
20. Lucht, M., Jahn, U., Barnow, S. and Freyberger, H. J. (2002) The use of a symptom checklist (scl-90-R) as easy method to estimate relapse risk after alcoholism detoxification therapy. European Addiction Research 8, 190-194.
21. Maître, M. (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Progress in Neurobiology 51, 337-361.
22. Maremmani, I., Lamanna, F. and Tagliamonte, A. (2001) Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. Journal of Psychoactive Drugs 33, 135-142.
23. Mayo-Smith, M. F. (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Journal of the American Medical Association 278, 144-151.
24. Miotto, K., Darakjian, J., Basch, J., Murray, S., Zogg, J. and Rawson, R. (2001) Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. American Journal of Addiction 10, 232-241.
25. Murphy, D. J., Shaw, G. K. and Clarke, I. (1983) Tiapride and chlormethiazole in alcohol withdrawal: a double-blind trial. Alcohol and Alcoholism 18, 227-237.
26. Nimmerrichter, A. A., Walter, H., Gutierrez-Lobos, K. E. and Lesch, O. M. (2002) Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol and Alcoholism 37, 67-73.
27. Peters, D. H. and Faulds, D. (1994) Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 47, 1010-1032.
28. Poldrugo, F. and Addolorato, G. (1999) The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol and Alcoholism 34, 15-24.
29. Renaudin, C. and Lemant, P. (1981) Comparative study of Atrium 300 and tiapride after oral administration for treatment of alcohol withdrawal syndrome. Psychologie Médicale 13, 161-168.
30. Saitz, R., Mayo-Smith, M. F., Roberts, M. S., Redmond, H. A., Bernard, D. R. and Calkins, D. R. (1994) Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. Journal of the American Medical Association 272, 519-523.
31. Schmidt, L. G., Kuhn, S., Smolka, M., Schmidt, K. and Rommelspacher, H. (2002) Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence. Progress in Neuro-psychopharmacology and Biological Psychiatry 26, 209-217.
32. Schuckit, M. A. (ed.) (1995) Drug and Alcohol Abuse. Plenum Medical Books, New York.
33. Shaw, G. K., Kolesar, G. S., Sellers, E. M., Kaplan, H. L. and Sandor, P. (1981) Development of optimal treatment tactics for alcohol withdrawal. Assessment and effectiveness of supportive care. Journal of Clinical Psychopharmacology 1, 382-388.
34. Shaw, G. K., Majumdar, S. K., Waller, S., MacGarvie, J. and Dunn, G. (1987) Tiapride in the long-term management of alcoholics of anxious or depressive temperament. British Journal of Psychiatry 150, 164-168.
35. Shaw, G. K., Waller, S., Majumdar, S. K., Alberts, J. L., Latham, C. J. and Dunn, G. (1994) Tiapride in the prevention of relapse in recently detoxified alcoholics. British Journal of Psychiatry 165, 515-523.
36. Steele, J. W., Faulds, D. and Sorkin, E. M. (1993) Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation. Drugs and Aging 3, 460-478.
37. Synthélabo (1347F690) Archive data report No. 1347F690 Laboratoires Delagrange Synthélabo (tiapride vs. meprobamate).
38. Synthélabo (1347F694) Archive data report No. 1347F694 Laboratoires Delagrange Synthélabo (tiapride vs. diazepame).
39. Victor, M. and Laureno, R. (1978) The neurologic compications of alcohol abuse: epidemiologic aspects. In Advances in Neurology, Vol. 19, Schoenberg, B. S. ed., pp. 603-617. Raven Press, New York.
40. Walter, H., Ramskogler, K., Semler, B., Lesch, O. M. and Platz, W. (2001) Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. Journal of Biomedical Science 8, 83-88.
41. Wetterling, T. and Veltrup, C. (1997) Diagnostik und Therapie von Alkoholproblemen. Springer, Berlin.
42. Wetterling, T., Kanitz, R. D., Veltrup, C. and Driessen, M. (1994) Clinical predictors of alcohol withdrawal delirium. Alcoholism: Clinical and Experimental Research 14, 71-75.
43. Wetterling, T., Kanitz, R. D., Besters, B., Fischer, D., Zerfass, B., John, U., Spranger, H. and Driessen, M. (1997) A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale). Alcohol and Alcoholism 32, 753-760.
44. Williams, H., Taylor, R. and Roberts, M. (1998) Gamma-hydroxybutyrate (GHB): a new drug of misuse. Irish Medical Journal 91, 56-57.